Has Katharine Batt received payments from drug or device companies?

Yes. Drug and device makers reported $153,491 in general payments to Katharine Batt across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katharine Batt did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katharine Batt come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katharine Batt

Internal Medicine · Winston Salem, NCNPI 1902061633

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $151,635 of the $153,491 with a category attached, or 98.8%. 12 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 32.3% of the total. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,491in general payments, 2019–2025

Across 142 payments — averaging $1080.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$50K
Novo Nordisk$42K
Bioverativ Therapeutics Inc.$20K
Regeneron$10K
Bristol Myers Squibb$10K
E.r. Squibb & Sons, L.L.C.$8K
plus $14K from 6 others

$17,324in research payments, 2019–2025

Across 15 payments — averaging $1154.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bayer$10K
Novartis$8K

What the payments were for

Consulting fees$151,63599%
Speaking & faculty fees$2500%
Travel & lodging$1,2891%
Food & beverage$3170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	45	$49,560
Novo Nordisk	3	$42,425
Bioverativ Therapeutics Inc.	18	$19,850
Regeneron	14	$10,016
Bristol Myers Squibb	7	$9,945
E.r. Squibb & Sons, L.L.C.	19	$8,125
Sanofi US Services Inc.	13	$4,480
Shire North American Group Inc	2	$2,925
AstraZeneca(2 entities)	12	$2,850
Jazz Pharmaceuticals Inc.	6	$2,340
Acadia Pharmaceuticals Inc	1	$520
Novartis	2	$455

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OBIZUR$18,770
ADYNOVATE$15,795
Luspatercept$9,100
VYXEOS$1,950
LYNOZYFIC$1,812
NO PRODUCT DISCUSSED$1,495
ADVATE$650
NUPLAZID$520
TAGRISSO$260

How this compares

$153,491 in reported general payments places this provider in the 95th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina →

Other internal medicine in Winston Salem

Jamy ArdWinston Salem$293K
Martin MurphyWinston Salem$42K
John PhippsWinston Salem$32K
Llewellyn MensahWinston Salem$28K
Nirmish ShahDurham$862K
Eugene WrightFayetteville$839K
Saad UsmaniCharlotte$551K
Bhakti PaulRaleigh$536K
Mary KlotmanDurham$478K
Manesh PatelDurham$435K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →